Karpus Investment Management’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-901,719
Closed -$10.8M 223
2025
Q2
$10.8M Sell
901,719
-13,175
-1% -$157K 0.35% 75
2025
Q1
$10.9M Sell
914,894
-40,465
-4% -$476K 0.35% 77
2024
Q4
$11.1M Sell
955,359
-5,825
-0.6% -$67.4K 0.33% 80
2024
Q3
$11M Sell
961,184
-4,670
-0.5% -$53.1K 0.31% 77
2024
Q2
$10.9M Buy
965,854
+171,475
+22% +$1.92M 0.31% 61
2024
Q1
$8.83M Buy
794,379
+50,225
+7% +$555K 0.25% 77
2023
Q4
$8.15M Buy
744,154
+90,565
+14% +$985K 0.25% 76
2023
Q3
$7.06M Hold
653,589
0.24% 88
2023
Q2
$6.97M Sell
653,589
-375
-0.1% -$3.97K 0.22% 96
2023
Q1
$6.86M Sell
653,964
-4,475
-0.7% -$46.5K 0.22% 101
2022
Q4
$6.75M Sell
658,439
-76,775
-10% -$779K 0.23% 102
2022
Q3
$7.35M Buy
+735,214
New +$7.37M 0.26% 92

Other funds holding RENE

Karpus Investment Management's RENE Position: Q3 2025 in Review

Karpus Investment Management sold out of Cartesian Growth Corp II (RENE) in Q3 2025, closing a stake of 901,719 shares — an estimated $10.8M sold.

Karpus Investment Management first reported a position in RENE in Q3 2022 and held it in 12 quarters. The position peaked at $11.1M in Q4 2024. 1 fund tracked by Wall St. Rank holds RENE as of Q3 2025.

  • Karpus Investment Management reported no remaining Cartesian Growth Corp II position as of Q3 2025 after selling out during the quarter.
  • Karpus Investment Management sold 901,719 Cartesian Growth Corp II shares in Q3 2025, an estimated $10.8M.
  • Karpus Investment Management first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 12 quarters.
  • Karpus Investment Management's Cartesian Growth Corp II position peaked at $11.1M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Cartesian Growth Corp II as of Q3 2025.

Based on Karpus Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.